Is Adeshwar Meditex overvalued or undervalued?

As of 29 August 2025, Adeshwar Meditex has moved from a fair to an attractive valuation grade. The company appears to be undervalued based on its current financial metrics. The PE ratio stands at 12.79, while the EV to EBITDA ratio is 8.97, and the Price to Book Value is notably low at 0.76. These ratios suggest that the company is trading at a discount relative to its earnings and book value.
In comparison to its peers, Adeshwar Meditex's valuation metrics are significantly more favorable. For instance, Poly Medicure has a PE ratio of 59.22, and Blue Jet Health has a PE of 32.28, both indicating a much higher valuation. Additionally, while Adeshwar Meditex has a PEG ratio of 4.28, peers like Raaj Medisafe, which is also attractive, have a much lower PEG of 0.34. Despite recent stock performance lagging behind the Sensex over the longer term, the current valuation suggests that Adeshwar Meditex presents a compelling investment opportunity.